Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

787 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis.
Kudo-Tanaka E, Ohshima S, Ishii M, Mima T, Matsushita M, Azuma N, Harada Y, Katada Y, Ikeue H, Umeshita-Sasai M, Miyatake K, Saeki Y. Kudo-Tanaka E, et al. Among authors: ohshima s. Clin Rheumatol. 2007 Oct;26(10):1627-33. doi: 10.1007/s10067-007-0558-5. Epub 2007 Feb 8. Clin Rheumatol. 2007. PMID: 17286215
Baseline anti-citrullinated peptide antibody (ACPA) titers and serum interleukin-6 (IL-6) levels possibly predict progression of bone destruction in early stages of rheumatoid arthritis (ERA).
Saeki Y, Kudo-Tanaka E, Ohshima S, Matsushita M, Tsuji S, Maeda Y, Yoshimura M, Watanabe A, Katada Y, Harada Y, Ichikawa K, Suenaga Y, Ohta Y, Tohma S; NHO iR-net Study Group. Saeki Y, et al. Among authors: ohshima s. Rheumatol Int. 2013 Feb;33(2):451-6. doi: 10.1007/s00296-012-2397-1. Epub 2012 Mar 29. Rheumatol Int. 2013. PMID: 22457007
Early therapeutic intervention with methotrexate prevents the development of rheumatoid arthritis in patients with recent-onset undifferentiated arthritis: A prospective cohort study.
Kudo-Tanaka E, Shimizu T, Nii T, Teshigawara S, Yoshimura M, Watanabe A, Tsuji S, Tsuboi H, Hirao M, Yura A, Harada Y, Sueishi M, Suenaga Y, Chiba N, Tonai T, Saisho K, Ogata A, Matsushita M, Hashimoto J, Ohshima S, Tohma S, Saeki Y. Kudo-Tanaka E, et al. Among authors: ohshima s. Mod Rheumatol. 2015;25(6):831-6. doi: 10.3109/14397595.2015.1031364. Epub 2015 Apr 30. Mod Rheumatol. 2015. PMID: 25800638
Elevated soluble CD14-subtype (PRESEPSIN; P-SEP) levels in rheumatoid arthritis (RA) patients with bacterial infection.
Tsuji S, Kitatoube A, Kikuchi-Taura A, Oguro E, Shigesaka M, Okita Y, Shimizu T, Nii T, Teshigawara S, Tanaka E, Harada Y, Matsushita M, Hashimoto J, Ohshima S, Takahashi G, Endo S, Saeki Y. Tsuji S, et al. Among authors: ohshima s. Mod Rheumatol. 2017 Jul;27(4):718-720. doi: 10.1080/14397595.2016.1246119. Epub 2016 Oct 27. Mod Rheumatol. 2017. PMID: 27785932 No abstract available.
Crosstalk between tumor necrosis factor-alpha signaling and aryl hydrocarbon receptor signaling in nuclear factor -kappa B activation: A possible molecular mechanism underlying the reduced efficacy of TNF-inhibitors in rheumatoid arthritis by smoking.
Nii T, Kuzuya K, Kabata D, Matsui T, Murata A, Ohya T, Matsuoka H, Shimizu T, Oguro E, Okita Y, Udagawa C, Yoshimura M, Kudo-Tanaka E, Teshigawara S, Harada Y, Yoshida Y, Isoda K, Tsuji SI, Ohshima S, Hashimoto J, Shintani A, Takehana Y, Tohma S, Saeki Y. Nii T, et al. Among authors: ohshima s. J Autoimmun. 2019 Mar;98:95-102. doi: 10.1016/j.jaut.2018.12.004. Epub 2018 Dec 25. J Autoimmun. 2019. PMID: 30591403
787 results